NIH
Despite the advances in the power of modern computers, there are still some bottlenecks in using computational fluid dynamics (CFD) due to computational time, limited grid resolution, pre- and post-processing of large simulation data sets, model parameter estimations, and uncertainty quantifications. Machine learning (ML) has been gaining more attention as a potential tool to alleviate such limitations that arise in CFD. The purpose of this grant is to develop a methodology to integrate ML with CFD models of generically orally inhaled drug products (OIDP) to promote alternative bioequivalence studies to enhance and accelerate the development and approval of generic OIDPs.